FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2017. The put-call ratio across all filers is 21.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $35,000 | -22.2% | 7,217 | +75.0% | 0.00% | -20.0% |
| Q4 2016 | $45,000 | +21.6% | 4,124 | +1.7% | 0.01% | +25.0% |
| Q3 2016 | $37,000 | +94.7% | 4,056 | +33.3% | 0.00% | +33.3% |
| Q2 2016 | $19,000 | +11.8% | 3,042 | +13.8% | 0.00% | +50.0% |
| Q1 2016 | $17,000 | +21.4% | 2,673 | +50.0% | 0.00% | +100.0% |
| Q4 2015 | $14,000 | – | 1,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|